#FoscarnetSodium

[theindianpharma]

#Foscarnet #FoscarnetSodium #Antiviral #CMV #Herpes #HIV #AIDS #Infusion #Treatment #InfectiousDisease #theindianpharma

[onhealth-blog]

Drug Shortages Update

FDA (U.S. Food and Drug Administration) [ http://www.fda.gov/?source=govdelivery ] You are subscribed to Drug Shortages for U.S. Food & Drug Administration (FDA). This information has recently been updated. *January 30, 2013* * Current Drug Shortages Index [ http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm?source=govdelivery ] (updated) * Drugs to be Discontinued: Methylprednisolone Sodium Succinate Injection [ http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm?source=govdelivery ]  * Drugs to be Discontinued: Foscarnet Sodium Injection [ http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm?source=govdelivery ] * Resolved Drug Shortages: Foscarnet Sodium (Foscavir) Injection [ http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050793.htm?source=govdelivery ]

#methylprednisolone #foscarnetsodium #foscarnet

[theindianpharma]

Foscavir: Antiviral Medication

Foscavir, an antiviral medication, serves as a vital intervention for combating cytomegalovirus (CMV) infections, particularly prevalent in immunocompromised individuals, notably those with AIDS-related symptoms. CMV infections pose severe health risks in individuals with compromised immune systems, often leading to life-threatening complications. Foscavir's mechanism of action targets the inhibition of viral replication, curtailing the spread and impact of CMV infections. By impeding the virus's ability to proliferate, Foscavir plays a crucial role in managing and controlling CMV-related illnesses, making it an indispensable therapeutic agent in the realm of infectious diseases, especially concerning immunocompromised patient populations vulnerable to CMV-associated complications.

#FoscarnetSodium #Foscarnet #AIDSTreatment #CMVInfection #CMVRetinitis #Antiviral

[onhealth-blog]

CDER New January 30, 2013

FDA (U.S. Food and Drug Administration) [ http://www.fda.gov/?source=govdelivery ] *What's New on the FDA Drugs Site* *January 29, 2013* * Current Drug Shortages Index [ http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm?source=govdelivery ] (updated) * Drugs to be Discontinued: Foscarnet Sodium Injection [ http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050794.htm?source=govdelivery ] * Resolved Drug Shortages: Foscarnet Sodium (Foscavir) Injection [ http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050793.htm?source=govdelivery ] * Drug Firm Annual Registration Status Download File [ http://www.fda.gov/Drugs/InformationOnDrugs/ucm135778.htm?source=govdelivery ] (updated) * Drug Firm Annual Registration Status [ http://www.accessdata.fda.gov/scripts/cder/drls/default.cfm?source=govdelivery ] (updated) * FDA approves new orphan drug Kynamro (mipomersen sodium) to treat inherited cholesterol disorder [ http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm337195.htm?source=govdelivery ] * Guidance for Industry: Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling (PDF - 131KB) [ http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM337169.pdf?source=govdelivery ] * National Drug Code Directory [ http://www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm?source=govdelivery ] (updated)

#foscarnetsodium #foscarnet